GATA6-mediated transcriptional activation and METTL3/IGF2BP2-dependent post-transcriptional stabilization upregulate CDC20 to promote the malignant progression of colorectal cancer and immune escape
Jul 2026· Human Cell· Vol 39· 0 citations· 41 references
Medicine
TL;DR
CDC20, upregulated transcriptionally by GATA6 and post-transcriptionally by METTL3, drove CRC progression, angiogenesis, and immune evasion and reversed the inhibitory effects of METTL3 knockdown on CRC cell malignancy and immune escape.
A specific mechanism whereby HOXC9 transcriptionally activates NRP1 is elucidated, thereby contributing to CRC malignant development and immune evasion and elucidate a specific mechanism whereby NRP1 overexpression could reverse CRC progression inhibition and immune function enhancement caused by HOXC9 downregulation.
Xiaofeng Qiu, Sheng Hu, Bingling Liao et al.· Zeitschrift für Induktive Ab...· 0 citations
The findings suggest that POLQ is a potential prognostic biomarker and therapeutic target, Though further validation in prospective, multicenter cohorts is warranted, andBioinformatic inference suggests a potential association with an immunosuppressive microenvironment, but this finding remains correlative and requires...
Li Li, Jian-Hua Wang, Fei-Long Zhou et al.· Oncology Research· 0 citations
Silencing of TMEM33 markedly suppresses CRC cell proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT) both in vitro and in vivo, and significantly reduces subcutaneous tumor growth and pulmonary metastatic burden.
Rui Li, Li Zhao, Nan-Nan Chai et al.· Human Cell· 0 citations
GATA2 inhibits EMT, invasion, and migration in UCEC by transcriptionally activating the ZNF486-JAM2 axis and provides a potential molecular framework for understanding UCEC progression.
Xing Fan, Zheng-Jia Tong, Ying-Xia Ou et al.· Frontiers in Oncology· 0 citations
MCM10 is aberrantly overexpressed in CRC and linked to worse clinical outcomes and its oncogenic effects involve METTL3/YTHDF1-mediated mRNA stabilization and enhanced M2 macrophage polarization, suggesting a potential role in immune microenvironment modulation.
Qiao Qu, Zhilong Li, Da-Lu Wang et al.· Cellular and Molecular Life...· 0 citations
A METTL3-m^6A-IGF2BP2 axis maintains MTFR1 expression to drive glycolytic reprogramming and CRC progression, and represents a prognostic biomarker and a potential therapeutic node linking epitranscriptomic regulation to metabolic adaptation in CRC.
Li-Qiang Wei, Deng-He Liu, Chun-Yu Lin et al.· Journal of Gastroenterology...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.